Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany (vol 17, e0278460, 2022)

被引：0
|
作者：
Schwarz, Florian [1 ]
Arefian, Habibollah [1 ]
Hartmann, Michael [1 ]
Runnebaum, Ingo [1 ]
机构：
[1] Canc Ctr Cent Germany, Jena, Germany
来源：
PLOS ONE | 2024年 / 19卷 / 05期
关键词：
D O I：
10.1371/journal.pone.0303776
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
    Schwarz, Florian
    Arefian, Habibollah
    Hartmann, Michael
    Runnebaum, Ingo
    PLOS ONE, 2022, 17 (12):
  • [2] Cost-Effectiveness Analysis of Advanced Radiotherapy Techniques for Breast Cancer Patients
    Xie, Y.
    Zhang, R.
    Guo, B.
    MEDICAL PHYSICS, 2020, 47 (06) : E733 - E733
  • [3] Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer
    Courtney, P. Travis
    Venkat, Puja S.
    Shih, Ya-Chen Tina
    Chang, Albert J.
    Lee, Alan
    Steinberg, Michael L.
    Raldow, Ann C.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [4] Locally Advanced Gastric Cancer Management: A Cost-Effectiveness Analysis
    Prasath, Vishnu
    Quinn, Patrick L.
    Arjani, Simran
    Li, Sharon
    Oliver, Joseph B.
    Mahmoud, Omar
    Jaloudi, Mohammed
    Hajifathalian, Kaveh
    Chokshi, Ravi J.
    AMERICAN SURGEON, 2024, 90 (06) : 1268 - 1278
  • [5] Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
    Lima, Antonio Olry de Labry
    Spacirova, Zuzana
    Fenix-Caballero, Silvia
    Hoces, Antonio Matas
    Vegas, Adrian Sanchez
    Aranzana, Manuel Cardenas
    Sierra-Sanchez, Jesus F.
    Martinez Diaz, Maria del Carmen
    del Rey, Emilio Jesus Alegre
    BREAST, 2021, 58 : 27 - 33
  • [6] Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis
    Kelly, Bridget N.
    Webster, Alexandra J.
    Lamb, Leslie
    Spivey, Tara
    Korotkin, Jenna E.
    Henriquez, Anthony
    Gadd, Michele A.
    Hughes, Kevin S.
    Lehman, Constance R.
    Smith, Barbara L.
    Specht, Michelle C.
    CLINICAL BREAST CANCER, 2022, 22 (05) : E700 - E707
  • [7] Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer
    Murphy, James D.
    Chang, Daniel T.
    Abelson, Jon
    Daly, Megan E.
    Yeung, Heidi N.
    Nelson, Lorene M.
    Koong, Albert C.
    CANCER, 2012, 118 (04) : 1119 - 1129
  • [8] Cost-effectiveness of talazoparib for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US
    Pan, Junjie
    Ren, Ning
    Ren, Lanqi
    Yang, YiBei
    Xu, Qiaoping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [9] COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN
    Chan, A. L.
    Leung, H. W.
    Lin, S. J.
    VALUE IN HEALTH, 2010, 13 (03) : A40 - A40
  • [10] RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
    Zou, Denise
    Niyazov, Alexander
    Arondekar, Bhakti
    Wu, Sherry
    BREAST, 2021, 60 : 302 - 302
12345